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Abstract
Background: Suitable and scalable in vitro culture conditions for parasite maintenance are needed to foster drug
research for loiasis, one of the neglected tropical diseases which has attracted only limited attention over recent
years, despite having important public health impacts. The present work aims to develop adequate in vitro culture
systems for drug screening against both microfilariae (mf) and infective third-stage larvae (L3) of Loa loa.
Methods: In vitro culture conditions were evaluated by varying three basic culture media: Roswell Park Memorial Institute
(RPMI-1640), Dulbecco’s modified Eagle’s medium (DMEM) and Iscove’s modified Dulbecco’s medium (IMDM); four sera/
proteins: newborn calf serum (NCS), foetal bovine serum (FBS), bovine serum albumin (BSA) and the lipid-enriched BSA
(AlbuMax® II, ALB); and co-culture with the Monkey Kidney Epithelial Cell line (LLC-MK2) as a feeder layer. The various
culture systems were tested on both mf and L3, using survival (% motile), motility (T90 = mean duration (days) at which at
least 90% of parasites were fully active) and moulting rates of L3 as the major criteria. The general linear model regression
analysis was performed to assess the contribution of each variable on the viability of Loa loa L3 and microfilarie. All
statistical tests were performed at 95% confidence interval.
Results: Of the three different media tested, DMEM and IMDM were the most suitable sustaining the maintenance of both
L. loa L3 and mf. IMDM alone could sustain L3 for more than 5 days (T90 = 6.5 ± 1.1 day). Serum supplements and LLC-MK2
co-cultures significantly improved the survival of parasites in DMEM and IMDM. In co-cultures with LLC-MK2 cells, L. loa mf
were maintained in each of the three basic media (T90 of 16.4–19.5 days) without any serum supplement. The most
effective culture systems promoting significant moulting rate of L3 into L4 (at least 25%) with substantial maintenance time
were: DMEM + BSA, DMEM + NCS, DMEM-AlbuMax®II, DMEM + FBS all in co-culture with LLC-MK2, and IMDM + BSA (1.5%)
, DMEM + FBS (10%) and DMEM + NCS (5%) without feeder cells. DMEM + 1% BSA in co-culture scored the highest
moulting rate of 57 of 81 (70.37%). The factors that promoted L. loa mf viability included feeder cells (β = 0.490), both
IMDM (β = 0.256) and DMEM (β = 0.198) media and the protein supplements NCS (β = 0.052) and FBS (β = 0.022); while
for L. loa L3, in addition to feeder cells (β = 0.259) and both IMDM (β = 0.401) and DMEM (β = 0.385) media, the protein
supplements BSA (β = 0.029) were found important in maintaining the worm motility.
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Conclusions: The findings from this work display a range of culture requirements for the maintenance of Loa loa stages,
which are suitable for developing an effective platform for drug screening.
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Background
Loiasis is a parasitic disease caused by the filarial nema-
tode Loa loa that is transmitted through the bite of an
infected Chrysops fly. Loiasis is endemic in the rainforest
areas of West and Central Africa [1]. The common
clinical signs of loiasis are the subconjunctival migration
of the adult worm, reported for the first time by Mongin
in 1770 [2], Calabar Swelling, pruritis, oedemas and
arthralgia. Interest in this filarial species, which has long
been considered to be less pathogenic than related
species [3], came from several reports in Cameroon indi-
cating that high microfilaraemia of L. loa is associated
with severe and sometimes fatal encephalopathic
reactions in patients who had taken ivermectin for
onchocerciasis treatment [4–7]. Loiasis is a neglected
tropical disease (NTD) which has attracted only limited
attention in drug research and development. Apart from
surgical removal of adult worms moving under the skin
or across the eye that can be done to relieve anxiety,
only two medications have so far been employed for
clinical cases since the last century, namely diethylcar-
bamazine (DEC) and albendazole. The latter is some-
times used in patients who are not cured with multiple
DEC treatments. Several cases of brain inflammation,
coma and death have been reported in people with heavy
infections when they are treated with DEC [8, 9]. The
risk of side effects has limited the deployment of mass
drug administration of ivermectin in areas where the L.
loa prevalence exceeds 20% [10–12], impeding the goals
stated by the African Programme for Onchocerciasis
Control (APOC) in areas of co-endemicity. Progress in
drug research and development for loiasis requires
suitable screening systems both at in vitro and in vivo
levels. Though innovations in filarial animal models have
recently been achieved [13, 14], in vitro maintenance
systems of the different stages of L. loa have not been
established. The present study aimed to design suitable
in vitro culture systems for drug screening against both
infective larvae (L3) and microfilariae (mf) of L. loa.
Methods
Isolation and purification of L. loa L3
Loa loa L3 were obtained from dissected Chrysops flies
that had previously fed on a consented microfilaremic
individual at Ediki Forest (South West region,
Cameroon). Engorged Chrysops were kept in captivity
for 12 days, to allow development to the infective stage
(L3). The flies were fed daily with 15% sucrose solution
soaked in cotton wool. After 12 days of rearing, the flies
were dissected in Petri dishes containing RPMI 1640
medium (Sigma-Aldrich, St Louis, USA). The head,
thorax and abdomen were separated and teased apart in
three different Petri dishes. Fly tissues were incubated
for 20 min to allow L3 larvae to migrate out. A sterile
pipette was used to pick the larvae and pooled in a shal-
low convex glass dish [15]. The worms were transferred
into 15 ml centrifuge tubes (Corning, Kennebunk-ME,
USA) for purification. Only L3 harvested from the head
(where more mature larvae are expected to be found)
were used in this study. The remaining larvae were
frozen to be used in other studies (immunology and
molecular biology). The L3 were washed using a Percoll®
(GE Healthcare, Pharmacia, Uppsala, Sweden) technique.
The L3 suspension concentrated in less than 1 ml RPMI
was slowly layered on the surface of a 15 ml tube con-
taining stock iso-osmotic Percoll® and centrifuged
(Humax 14k human, Germany) at 800× rpm for 10 min.
The process was repeated to remove microbial contami-
nants. At the end, the L3 were washed twice with RPMI-
1640 by centrifugation at 1500× rpm for 10 min to
remove Percoll® remnant.
Isolation and purification of L. loa mf
Loa loa mf were obtained from baboons (Papio anubis)
experimentally infected with human strain of L. loa
reared in Kumba Medical Research Station (South West
region, Cameroon). Peripheral blood samples of hyper-
microfilaraemic baboons were collected as described in
the previous reports [13]. Microfilaraemic loads were de-
termined microscopically on thick films. Calibrated thick
blood smears were prepared by spreading a 50 μl venous
blood sample from a 75 μl non-heparinised capillary
tube, onto a clean slide over an area of 1.5 × 2.5 cm
[16]. After drying, films were dehemoglobinized and
stained with Giemsa. The Percoll® density centrifugation
method previously described [17] was used to purify mf
from infected blood samples.
In vitro culture of parasites
Four supplements were used at 3 concentrations each:
fetal bovine serum (Lonza) and newborn calf serum
(Sigma-Aldrich, Berlin, Germany) at 15%, 10% and 5%;
bovine serum albumin (Sigma-Aldrich, Berlin, Germany)
and AlbuMax® II (Gibco Life Technologies, Cergy-
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Pontoise, France) at 1.5%, 1% and 0.5%. Three basic
media were used: RPMI-1640 and IMDM (Sigma-Aldrich,
St Louis, USA) and DMEM (Gibco Life Technologies,
Cergy-Pontoise, France). Ciprofloxacin (5 μg/ml) was used
as antibiotic and fluconazole (10 μg/ml) as antifungal. Flat
bottom culture plates (48-well) with lids (Corning, Kenne-
bunk, ME, USA) were loaded as follows: 800 μl of the dif-
ferent media with a range of 20–30 microfilariae or 10–15
larvae per well. Cultures were carried out in triplicates.
Monkey kidney cell co-culture
Monkey kidney epithelial cells (LLC-MK2) (ATCC, USA)
were cultured in flasks at 37 °C in a CO2 incubator
(Sheldon Mfg. Inch, Cornelius, OR, USA) at 5% CO2
until the cell layer became fully confluent. For new inoc-
ulations and other cell manipulations, trypsin was used
to detach cells from the walls of the flasks. Cells were
then dislodged with trypsin solution (25%) containing
EDTA, the mixture was kept at 37 °C for less than 1 h.
The cell suspension was centrifuged at 1,500 rpm for 10
min, the supernatant was discarded, and the pellet re-
suspended and diluted to 105 cells/ml in complete
culture medium. Aliquots (100 μl) of cell suspensions
were plated into a 48-well culture plate and kept in the
incubator for cells to become fully confluent.
Assessment of parasite viability
The viability of the parasites was assessed daily, by visual
inspection (by two individuals) under an inverted micro-
scope until they die. Their motility was scored on a 4-
point scale [18, 19]: 0, no movement or immotile; 1,
intermittent shaking of head and tail; 2, sluggish
(shaking of the whole worm on a spot); 3, vigorous
movement (shaking of the whole worm and migration
from one spot to was considered).
Data processing and analysis
Three different batches of L3 larvae and microfilariae
were used for each culture system. For each batch of
parasites, 4 replicate wells were used per system. Raw
data collected daily on record sheets were entered into a
template designed on Microsoft Excel 2007. Three vari-
ables were defined and computed to assess the viability
of the parasites (mean motility and mean mortality, T90).
Motility variable was computed based on the scoring
system described above, and using the following formula.
Motility %ð Þ ¼
P
SiNi
3:
P
Ni
 100
where Si is the score of point scale i and Ni is the total
number of worms at a point scale i.
The variable T90 was defined as the duration at which
90% of the worms were still fully active (score 3 above)
in the well. This variable was set as one of the major
indicators of the suitability of the culture system, with
relevance to drug screening for loiasis. From values
obtained after testing each system on three batches of
parasites, T90 values were expressed as mean ± standard
deviation.
The Kruskal-Wallis test was used to assess the global
significant differences between the distribution of the me-
dian T90 across media and supplements, and the pairwise
multiple comparisons of the ranked data was performed
using the Pairwise Multiple Comparisons of Mean Rank
(PCMR) package in R version 3.1.4. Mann-Whitney U-test
was used to compare the the medians of the T90 between
the cell free and cell containing culture. Statistical tests
were interpreted using a 5% significance level. It was con-
sidered that a valid appreciation of the effect of any drug
could be possible only in a system where at least 90% of
parasites motility were sustained till the end of the
experiment.
Factors that promoted parasite survival were identified
using the multiple linear regression. The general linear
model (GLM) was built using the hierarchical stepwise
method. A total of 5 blocks were achieved with the 5
factors (incubation time, presence of feeder cells, basic
medium, serum/protein, protein concentration) and
those that contributed significantly to the improvement
of the model were identified based on the F-statistics
and the adjusted R-square (Additional file 1: Table S1).
The incubation time was treated as a metric factor.
Dichotomous variables such as the presence of monkey
kidney cells were coded using binary figures. For each
nominal or ordinal factor (Basic culture media, protein
or protein concentration), sets of dummy variables were
created and compared to one of the categories defined
as reference. While RPMI-1640 was used as a reference
against DMEM and IMDM, the four sera (Albumax II,
BSA, FBS and NCS) were compared to the serum free
culture (No serum). The three concentrations of each
serum (0.5%, 1% and 1.5% for Albumax II and BSA; 5%,
10% and 15% for FBS and NCS) were labelled using the
three ordinal levels: low, medium and high concentra-
tion; they were also compared to the serum-free
culture. Interaction factors were created between ex-
planatory variables and added to the models. The pre-
diction of the motility by the protein concentration
was poor, and there was a non-statistical difference
between different concentrations of protein as will be
discussed latter. Based on experimental observations,
interactions were expected between the other three
variables. Therefore, two ways and three ways inter-
action terms were created between those three experi-
mental parameters: the presence of feeder cells, the
culture medium used in reference to RPMI1640 and
the type of protein supplement.
Zofou et al. Parasites & Vectors  (2018) 11:275 Page 3 of 15
The passage of the L. loa larvae from the third (L3) to
the fourth (L4) stages was further considered the second
target product profile in assessing the suitability of the
culture systems tested. For each of the 78 culture sys-
tems designed and evaluated, the moulting rate (percent-
age of moulted worms) as well as the timeframe was
computed.
Results
Evaluation of the effect of each basic culture medium on
the viability of L. loa L3 and mf
The T90 values of the parasite motility in different basic
media were evaluated and results are presented in Fig. 1
and the statistical report in Table 1. The values of T90
ranged from 3.0 day to 6.5 days for L3. In the absence of
protein supplement and feeder cells, there were significant
difference between the T90 value of the 3 media vis a vis the
L3 (χ2 = 38.793, df = 2, P < 0.0001) and mfs (χ2 = 38.793,
df = 2, P < 0.0001). Pairwise comparison indicated
that L3 survived longer particularly in IMDM compared
to DMEM (P < 0.0001) and RPMI (P < 0.0001),
whereas mf hardly exceeded 3 days survival,
irrespective of the culture medium tested in absence
of supplements. However, mf survival time was
significantly higher in DMEM than in RPMI (P < 0.0001)
or IMDM (P = 0.0010).
Evaluation of the effect of serum/protein
supplementation on the viability of L. loa larvae and
microfilariae in culture
Figure 2 and Fig. 3 show the effect of serum/protein
supplements in various basic media with regards to the
mean values of T90 of L. loa L3 and mf, respectively.
Effect of serum/protein on the viability of L. loa larvae
AlbuMax® II
Generally, the supplementation of DMEM and IMDM
with AlbuMax® II promoted the viability of larvae, in-
creasing T90 by 1.5–2.5-fold. RPMI supplemented with
AlbuMax® II inhibited the larvae viability (T90 < 1 day,
Fig. 2a).
Fetal bovine serum (FBS)
This serum could support the viability of larvae for up
to 8.7 days when IMDM was supplemented with 10%
FBS. T90 > 5 days was observed in all concentrations of
FBS except in the RPMI supplement medium (Fig. 2b).
Bovine serum albumin (BSA)
All media supplemented with BSA also improved larvae
viability with T90 ≥ 5 days, except for DMEM supple-
mented with 1% BSA and all concentrations of BSA with
RPMI (Fig. 2c).
a b
Fig. 1 Effect of each basic medium on the mean values of T90 of L. loa L3 (a) and microfilarae (b). Microfilariae and infective larvae of Loa loa
were cultured with three different media (RPMI, DMEM and IMDM) without neither serum supplement, nor feeder cells. Pairwise multiple
comparisons: Dunn’s post-hoc test for multiple comparisons of independent samples. The P-values indicated here are those that were found
significant when comparing two basic media. Number of observations: n = 12. Abbreviations: DMEM, Dulbecco’s modified Eagle’s medium; IMDM,
Iscove’s modified Dulbecco’s medium; RPMI, Roosevelt Memorial Park Institute; L3, third-stage infective larva; T90, mean duration at which 90% of
parasites were fully active
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Table 1 Statistical report on the effect of serum/protein concentration in various culture systems with regards to the mean values
of T90 of L. loa microfilariae and L3
Parasite Feeder layer Medium Protein Kruskal-Wallis χ2 df P-value
Loa loa mf No DMEM Albumax 4.2585 3 0.2349
BSA 9.1681 3 0.0271
FBS 9.6542 3 0.0218
NCS 9.5639 3 0.0227
IMDM Albumax 16.1960 3 0.0010
BSA 22.8860 3 < 0.0001
FBS 19.1060 3 0.0003
NCS 23.1030 3 < 0.0001
RPMI Albumax 20.5860 3 0.0001
BSA 17.1480 3 0.0007
FBS 7.5795 3 0.0556
NCS 11.3590 3 0.0099
LLC-MK2 DMEM Albumax 6.9561 3 0.0733
BSA 6.1987 3 0.1023
FBS 4.9629 3 0.1745
NCS 6.1198 3 0.1059
IMDM Albumax 0.7759 3 0.8552
BSA 1.7466 3 0.6266
FBS 3.0427 3 0.3851
NCS 0.8119 3 0.8466
RPMI Albumax 16.8520 3 0.0008
BSA 14.6670 3 0.0021
FBS 0.3286 3 0.9546
NCS 2.3611 3 0.5009
Loa loa L3 No DMEM Albumax 7.0250 3 0.0711
BSA 8.3441 3 0.0394
FBS 8.1322 3 0.0434
NCS 6.0725 3 0.1081
IMDM Albumax 1.7999 3 0.6150
BSA 1.8722 3 0.5993
FBS 3.8436 3 0.2789
NCS 9.6063 3 0.0222
RPMI Albumax 8.4292 3 0.0379
BSA 4.2135 3 0.2393
FBS 6.5292 3 0.0885
NCS 1.4905 3 0.6845
LLC-MK2 DMEM Albumax 1.8177 3 0.6111
BSA 1.3618 3 0.7145
FBS 5.8987 3 0.1166
NCS 1.6916 3 0.6388
IMDM Albumax 16.0890 3 0.0011
BSA 5.2627 3 0.1535
FBS 2.1496 3 0.5419
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Newborn calf serum (NCS)
Considering media supplemented with NCS, only DMEM
with 5% NCS, IMDM with 10/15% NCS had T90 > 5 days
(Fig. 2d). Considering the 5-day cut-off point for drug
screening, up to twenty culture media formulated based on
the two basic culture media (DMEM and IMDM) and the
four serum/protein supplements can be exploited for Loa
L3 in priority: DMEM with 0.5% AlbuMax® II (T90 = 5.5 ±
1.9), 1% AlbuMax® II (T90 = 6.6 ± 2.4), 1.5% AlbuMax® II
(T90 = 6 ± 1.8), 0.5% BSA (T90 = 7.2 ± 0.3), 1.5% BSA
(T90 = 5 ± 1.9), 5% FBS (T90 = 6.3 ± 2), 10% FBS (T90 = 7.8
± 2.2), 5% FBS (T90 = 7.3 ± 2.7), 5% NCS (T90 = 6.4 ± 2.5),
and IMDM with 0.5% AlbuMax® II (T90 = 8.5 ± 3.8), 1%
AlbuMax® II (T90 = 8 ± 2.5), 1.5% AlbuMax® II (T90 = 6.8 ±
2.5), 0.5% BSA (T90 = 6.7 ± 1.2), 1% BSA (T90 = 6.2 ± 1.5),
1.5% BSA (T90 = 7 ± 2.2), 5% FBS (T90 = 7.1 ± 3), 10% FBS
(T90 = 8.7 ± 2.6), 15% FBS (T90 = 7.7 ± 3.1), 10% NCS
(T90 = 7.1 ± 2.4), 15% NCS (T90 = 8.1 ± 2.9).
Table 1 Statistical report on the effect of serum/protein concentration in various culture systems with regards to the mean values
of T90 of L. loa microfilariae and L3 (Continued)
Parasite Feeder layer Medium Protein Kruskal-Wallis χ2 df P-value
NCS 4.9566 3 0.1750
RPMI Albumax 6.2386 3 0.1006
BSA 5.5548 3 0.1354
FBS 4.0227 3 0.2590
NCS 5.6006 3 0.1327
a b
c d
Fig. 2 Effect of serum/protein supplements in various basic media with regards to the mean values of T90 of L. loa L3. Infective larvae of Loa loa
were cultured with three different media (RPMI, DMEM and IMDM) with each of the four serum/protein supplements [Albumax (a), FBS (b), BSA
(c) and NCS (d)] without feeder cells. Pairwise multiple comparisons: Dunn’s post-hoc test for multiple comparisons of independent samples. The
P-values indicated here are those that were found significant when comparing two concentrations of the serum/protein. Number of observations:
n = 12. Abbreviations: DMEM, Dulbecco’s modified Eagle’s medium; IMDM, Iscove’s modified Dulbecco’s medium; RPMI, Roosevelt Memorial Park
Institute; BSA, bovine serum albumin; FBS, fetal bovine serum; NCS, newborn calve serum; L3, third-stage infective larva; T90, mean duration at
which 90% of parasites were fully active
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Effect of serum/protein on the viability of L. loa
microfilariae
AlbuMax® II
All concentrations of AlbuMax® II supplement improve
the viability of mf regardless the basic medium except
for RPMI. Although the improvement was noticeable, all
T90 were less than 5 days as shown in Fig. 3a.
Fetal bovine serum (FBS)
All concentrations of fetal bovine serum improved para-
site viability but T90 > 5 days was reported only with
FBS supplemented DMEM and IMDM (Fig. 3b).
Bovine serum albumin (BSA)
Generally, BSA boosted the microfilariae viability. The
T90 values above 5 days were reported with all con-
centrations of BSA supplemented DMEM and IMDM
+ 0.5% BSA (Fig. 3c).
Newborn calf serum (NCS)
With respect to media supplemented with NCS, only
RPMI supplemented with 10% NCS could not sustain the
L. loa mf for up to T90 = 5 days. Generally, NCS supple-
mentation improved the L. loa mf viability by up to 4-fold
as compared to basic medium without protein supplement
(DMEM with 10%NCS, T90 = 12 ± 1 days and DMEM
only, T90 = 3 ± 0.4 days), respectively (Fig. 3d).
With respect to Loa mf, none of the media supple-
mented with AlbuMax® II irrespective of the protein
concentration could improve microfilaria viability for up
to T90 ≥ 5. Nevertheless, up to eighteen culture media
formulations based on all three basic culture media and
the four serum/protein supplements had interesting T90
values. These are DMEM with 0.5% BSA (T90 = 7. 3 ± 1.
8), 1% BSA (T90 = 6.2 ± 1.4), 1.5% BSA (T90 = 6.7 ± 1.7),
5% FBS (T90 = 6 ± 3.1), 10% FBS (T90 = 7.5 ± 2.9), 15%
FBS (T90 = 7.7 ± 1.7), 5% NCS (T90 = 9.3 ± 4.4), 10%
NCS (T90 = 12 ± 1), 15% NCS (T90 = 9.6 ± 2.5); IMDM
with 0.5% BSA (T90 = 7.4 ± 3.1), 5% FBS (T90 = 11.2 ± 2.
a b
c d
Fig. 3 Effect of serum/protein supplements in various basic media with regards to the mean values of T90 of L. loa microfilariae. Microfilariae of
Loa loa were cultured with three different media (RPMI, DMEM and IMDM) with each of the four serum/protein supplements [Albumax (a), FBS
(b), BSA (c) and NCS (d)] without feeder cells. Pairwise multiple comparisons: Dunn’s post-hoc test for multiple comparisons of independent
samples. The P-values indicated here are those that were found significant when comparing two concentrations of the serum/protein. Number of
observations: n = 12. Abbreviations: DMEM, Dulbecco’s modified Eagle’s medium; IMDM, Iscove’s modified Dulbecco’s medium; RPMI, Roosevelt
Memorial Park Institute; BSA, bovine serum albumin; FBS, fetal bovine serum; NCS, newborn calve serum; T90: mean duration at which 90% of
parasites were fully active
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6), 10% FBS (T90 = 10.2 ± 1.9), 15% FBS (T90 = 11.5 ± 3.
3), 5% NCS (T90 = 6.1 ± 1.2), 10% NCS (T90 = 6.8 ± 1.2)
, 15% NCS (T90 = 7.5 ± 1.4) and RPMI with 5% NCS
(T90 = 5.4 ± 4.9), 15% NCS (T90 = 5.1 ± 3.2).
Assessment of the importance of monkey kidney cells as
feeder layer
The findings on the effect of the monkey kidney epi-
thelial cells as feeder on the survival of the L. loa L3
and mf are summarized in Fig. 4 and Fig. 5, respect-
ively and the summary of the statistical report is
presented in Table 2. Co-culture of L3 or mf with
LLC-MK2 cells significantly improved the longevity
of parasites culture with each basic media in the ab-
sence of serum/protein supplements. With respect to
Loa L3, only DMEM with LLC-MK2 (No serum/protein
supplement) enhanced viability by 3-fold (9.8 ± 2.7), as
compared to DMEM without serum (T90 of 3 ± 1). It was
not the case regarding IMDM with LLC-MK2 (T90 = 5.8
± 2.4) and RPMI with LLC-MK2 (T90 = 5.2 ± 2). When
combining feeder cells with serum/protein supplements,
the parasite survival and motility were even more in-
creased, with highest T90 per basic culture medium vary-
ing from 10.0 (5% FBS in IMDM) to 17.8 days (5% NCS in
DMEM).
Co-culture of microfilariae with feeder cells increased
T90 values up to 7-fold (22.5 ± 2.7 days). All serum/pro-
tein supplemented systems in co-culture were suitable
(T90 significantly greater than 5 days) with DMEM and
IMDM; but RPMI supplemented with AlbuMax® II
remained sub-standard despite the presence of LLC-
MK2 feeder layer. Microfilariae co-cultured on LLC-
MK2 in basic culture media alone T90 values (DMEM
T90 = 19.5 ± 2.8; IMDM T90 = 19.5 ± 5.2; and RPMI T90
= 16.4 ± 1.7) were not statistically different from their
best protein/serum supplemented counterpart (0.5%
BSA supplemented DMEM on LLC-MK2 T90 = 22.5 ±
2.7; 5% NCS supplemented IMDM on LLC-MK2 T90 =
20.3 ± 4.9; and 1% BSA supplemented RPMI on LLC-
MK2 T90 = 20.8 ± 1.6). The ranking of the observed T90
values of the various tested systems are summarised in
Additional file 2: Table S2.
a b
c d
Fig. 4 Effect of monkey kidney cells in various serum/protein supplemented basic media with regards to the mean values of T90 (days) of L. loa
L3. The black arrows indicate the T90 values in absence of the feeder cells. Infective larvae of Loa loa were cultured with three different media
(RPMI, DMEM and IMDM) with each of the four serum/protein supplements [Albumax (a), FBS (b), BSA (c) and NCS (d)] and (LLC-MK2) feeder
cells. For each medium and each concentration of the serum/protein, culture with monkey kidney cells was compared to serum free culture
(Mann-Whitney U-test). Number of observations: n = 12. Abbreviations: DMEM, Dulbecco’s modified Eagle’s medium; IMDM, Iscove’s modified
Dulbecco’s medium; RPMI, Roosevelt Memorial Park Institute; BSA, bovine serum albumin; FBS, fetal bovine serum; NCS, newborn calve serum; L3,
third-stage infective larva; T90, mean duration at which 90% of parasites were fully active; ¥: significantly different from the equivalent cell
free culture
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Effect of the different culture systems on the moulting
from L3 to the fourth-stage larvae of L. loa
Moulting was observed following L. loa L3 culture, but
its occurrence varied widely with culture conditions with
values up to 70.37% (in 1% BSA supplemented DMEM
in co-culture with LLC-MK2). Variation in moulting rate
are presented in Figs. 6, 7 and 8, Additional file 3: Table
S3, with an illustration in Fig. 9. The proportion of
moulting recorded with RPMI was below 25%. This con-
trasted with DMEM and IMDM where significant
moulting rates were noted, both in cell-free and co-
culture of L3 with LLC-MK2. Apart from the isolated
case of IMDM with up to 27.27% (24 moulted worms
out of a total of 88), serum/protein supplementation was
found indispensable for the transition from L3 to L4 in
vitro. The higher moulting rates were generally observed
with DMEM, compared to IMDM. The highest moulting
rate was observed in protein and feeder layer supple-
mented DMEM as illustrated in Fig. 6. Loa loa L3
moulting began on day 9 and observation was continued
until day 29, supplementation with BSA scored highest
moulting rates, with 57.32, 70.37 and 58.62% larvae
moulted in 0.5, 1 and 1.5% BSA supplement,
respectively.
Linear regression analysis of different factors that
influence the in vitro maintenance of L. loa microfilariae
and L3
Bivariate analysis indicated strong association between
motility and incubation time (Spearman’s rho = -0.674,
P < 0.001). This was the first to be introduced in the sin-
gle linear regression analysis (R2 = 0.452), and the
remaining variables were successively added to construct
the final GLM. Before interaction terms were introduced
in the models, the important factors that contributed to the
improvement of worm motility were identified separately
based on their standardized coefficient (Fig. 10). For Loa
loa mf, these factors included feeder cells (β = 0.490), both
IMDM (β = 0.256) and DMEM (β = 0.198) media and the
protein supplements NCS (β = 0.052) and FBS (β = 0.022);
for Loa loa L3, in addition to feeder cells (β = 0.259)
and both IMDM (β = 0.401) and DMEM (β = 0.385)
a b
c d
Fig. 5 Effect of monkey kidney cells in various serum/protein supplemented basic media with regards to the mean values of T90 of L. loa
microfilariae. Microfilariae of Loa loa were cultured with three different media (RPMI, DMEM and IMDM) with each of the four serum/protein
supplements [Albumax (a), FBS (b), BSA (c) and NCS (d)] and (LLC-MK2) feeder cells. For each medium and each concentration of the serum/
protein, culture with monkey kidney cells was compared to serum free culture (Mann-Whitney U-test). Number of observations: n = 12. Abbreviations:
DMEM, Dulbecco’s modified Eagle’s medium; IMDM, Iscove’s modified Dulbecco’s medium; RPMI, Roosevelt Memorial Park Institute; BSA, bovine serum
albumin; FBS, fetal bovine serum; NCS, newborn calve serum; T90, mean duration at which 90% of parasites were fully active; ¥, significantly different
from the equivalent cell free culture
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media, the proteins supplement BSA (β = 0.029) were
found important for the maintenance of the worm
motility.
From the built models, the important variables re-
quired to meet the threshold of T90 are as followed and
classified with respect to their importance. Feeder cells
Table 2 Summary statistics on the effect of the addition of monkey kidney cells in various serum/protein supplemented basic
media with regards to the mean values of T90 of L. loa L3 and microfilariae
Medium Serum/
Protein
Concentration
(%)
Loa loa L3 Loa loa mf
Mann-Whitney U P-value Mann-Whitney U P-value
DMEM No serum 32 0.0084 24 0.0139
Albumax 0.5 16 0.0452 12 0.0471
1 16 0.0476 35 0.0025
1.5 21 0.0467 16 0.0286
BSA 0.5 15 0.0167 12 0.0471
1 19 0.0171 48 0.0006
1.5 14 0.0462 32 0.0040
FBS 5 6 0.5462 15 0.0357
10 15 0.0167 24 0.0095
15 12 0.0448 35 0.0025
NCS 5 15 0.0167 6 0.0200
10 22 0.0381 20 0.0159
15 24 0.0095 20 0.0158
IMDM No serum 25 0.4945 56 0.0003
Albumax 0.5 20.5 0.7479 54 0.0004
1 36 0.0137 80 0.0004
1.5 21.5 0.9999 70 0.0001
BSA 0.5 14.5 0.6303 36 0.0069
1 32 0.0345 96 0.0002
1.5 25 0.9497 96 0.0002
FBS 5 26 0.024 18 0.0257
10 12 0.1419 91 0.0003
15 11 0.1079 72 0.0490
NCS 5 31 0.0411 54 0.0004
10 38 0.0813 96 < 0.0001
15 31 0.0414 96 < 0.0001
RPMI No serum 26 0.0109 98 0.0003
Albumax 0.5 14 0.2413 32.5 0.3170
1 20 0.1087 83 0.0685
1.5 10 0.7483 86 0.1764
BSA 0.5 6 0.9999 40 0.002
1 9 0.4000 77 < 0.0001
1.5 17 0.0111 77 0.0006
FBS 5 15 0.3571 35 0.0057
10 16 0.2857 56 < 0.0001
15 16 0.1905 91 0.0004
NCS 5 6.5 0.9999 29 0.0282
10 9 0.4000 88 0.0003
15 13 0.2000 88 0.0003
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were found as the most important. In combination to
DMEM (DMEM-LLCMK2), the unstandardized coeffi-
cient decreased although the interaction was the best
among others. In addition, the combination of three var-
iables (feeder layer-basic culture medium-protein/serum
supplement) was not mandatory as the interaction
LLCMK2-Albumax instead weakened the model with a
negative coefficient.
The model was diagnosed by assessing the assump-
tions of normal distribution and homoscedasticity.
The histogram of the residuals (errors) in the model
was used to check if they are normally distributed
(Additional file 4: Figure S1). Although not perfect,
the frequency distribution of the residuals has a
shape close to that of the normal Gauss curve, indi-
cating evidence of normal distribution. Additionally,
P-P plot was used for further check (Additional file 5:
Figure S2). Here, the expected and observed cumulative
probabilities were closed suggesting that the assumption
of normal distribution of the residual was far to be not vi-
olated. The scatterplot of standardized residuals against
standardized predicted values were used to assess the
assumption of homoscedasticity (Additional file 6:
Figure S3). The variance of residuals were random
distributed indicating that the assumption of homo-
scedasticity was likely to be safe.
Fig. 6 Effects of serum/protein supplements at different concentrations added to DMEM basic medium with or without feeder layer on the
moulting L. loa infective larvae in culture. Number of observations: n = 12. Abbreviation: DMEM: Dulbecco’s modified Eagle’s medium
Fig. 7 Effects of serum/protein supplements at different concentrations added to IMDM basic medium with or without feeder layer on the
moulting L. loa infective larvae in culture. Number of observations: n = 12. Abbreviation: IMDM: Iscove’s modified Dulbecco’s medium
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Discussion
Drug discovery research for L. loa has so far attracted
only very limited attention compared to other filarial
diseases. Repurposing attempts have been conducted
with existing drugs with only limited success. The effect
of several antimalarial drugs (quinine, chloroquine, amo-
diaquine and artesunate) was investigated on loiasis in a
randomized, placebo-controlled approach in central
Cameroon [20]. This study recorded no significant
change in parasite loads in any of the treatment groups.
Another study tested different intermittent doses of
albendazole on Loa loa microfilaraemia, the reduction in
mf load obtained was insufficient to prevent the risk of
severe adverse reactions during ivermectin mass drug
administration in loiasis co-endemic areas [21]. These
observations demonstrated that repurposing of existing
antiparasitic therapies may not be a suitable approach to
develop drugs with satisfactory therapeutic window. The
traditional approach starting from standard in vitro
discovery through preclinical and clinical testing necessi-
tates in vitro maintenance of L. loa stages for a mini-
mum duration required for drug screening. Herein we
designed and tested the effect of varying 78 culture con-
ditions on both L3 and mf viability starting with three
basic culture media, four serum/protein supplements
and one feeder cell. In general, L. loa L3 survived for
longer periods than mf in the different basic culture
media with neither protein nor feeder cell supplementa-
tion. For the maintenance of L3, IMDM exhibited the
best performance, whereas on microfilariae, DMEM had
the highest T90 though only three-day survival. Consi-
dering a minimum cut-off point of five-day maintenance
of 90% highly active larvae or microfilariae for in vitro
drug screening on L. loa microfilariae and infective
Fig. 8 Effects of serum/protein supplements at different concentrations added to RPMI basic medium with or without feeder layer on the
moulting L. loa infective larvae in culture. Number of observations: n = 12. Abbreviation: RPMI: Roosevelt Memorial Park Institute
Fig. 9 Image of moulted worms observed under inverted microscope. a Fully moulted Loa L4 larva. b Cast cuticule from moulted Loa L3 (arrows)
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larvae, IMDM was the only basic medium that could be
employed as such without any need of protein supple-
ment/feeder layer. However, none of the media would be
suitable for in vitro investigations requiring longer pe-
riods of incubation.
Four different serum/protein supplements were there-
fore applied at increasing concentrations to the three
basic culture media in order to improve their nutritional
potencies for both L3 and mf. The results obtained were
highly diverse. In RPMI, serum/protein supplementation
rather caused drop in T90 which was more pronounced
for AlbuMax® II followed by FBS, NCS and BSA, in both
L3 and mf. Consequently, none of the formulations
based on RPMI supplemented with serum/protein (with-
out feeder layer) was successful in keeping mf alive and
active for more than five days. Mengome et al. [22] re-
cently reported on screening of 12 methanolic extracts
of nine traditional plant remedies employed in Gabon,
on L. loa mf maintained in vitro using modified Eagle’s
medium supplemented with 10% foetal calf serum with
five-day incubation time. Our findings showing an aver-
age T90 value of 7.5 ± 2.9 days and thus corroborate the
data reported by these authors, confirming the suitability
of the culture system employed.
A drastic increase in the survival time and viability of
the L. loa mf was obtained with addition of LLC-MK2
cells as feeder layer, except for AlbuMax® II in RPMI. The
T90 values were extended for all culture formulations
(except AlbuMax® II in RPMI), even exceeding 20 days.
The hypothesis that LLC-MK2 cells alone can be
enough to sustain the viability of the L. loa parasites in
vitro was tested. In all the three basic culture media,
RPMI, DMEM and IMDM, without serum/protein
supplement, parasites could still survive 15 days and be-
yond. Toback et al. [23] reported that monkey kidney
cells during their growth in vitro produce growth factors
such as the epidermal growth factor (EGF), interleukin
growth factor (IGF) and transforming growth factor
(TGF-β). Thus, these factors are possibly supportive of
L. loa larval growth and/or survival, which facilitate their
in vitro maintenance.
Culture systems capable of sustaining moulting of in-
fective larvae present an additional advantage for in vitro
investigations on the parasite, including both physio-
logical studies and the exploration of drug targets. In
addition to the survival of parasites, the effect of the dif-
ferent culture systems on the moulting of L3 was further
examined. Maintenance and moulting of filariae larvae
using different culture systems have been reported for
Onchocerca spp. [24, 25], Wuchereria bancrofti [26–29]
and Brugia malayi [30, 31]. The present study is the first
attempt to optimise such systems for L. loa larvae.
Of the total of 659 moulted worms observed, the
distribution with respect to each medium was as
followed: DMEM (70%) followed by IMDM (29%) and
finally RPMI (1%). The proportion of moulting ob-
served in DMEM + LLC-MK2 varied with the nature
of the serum/protein supplement. 62.44% (138/221) in
BSA, 30.15% (79/262) in NCS, 24.52% (64/261) in
AlbuMax® II and 22.38% (45/201) in FBS. The moul-
ting rate in BSA was statistically different (P < 0.001)
from the three other sera. With BSA supplementa-
tion, 1% proved to be optimum with a 70.37% moul-
ting rate, compared with 1.5% and 0.5% with rates of
Fig. 10 Graphical representation of the standardized coefficients of the main effects of different factors on the predicted Loa loa microfilariae and
L3 motility. Adjusted R2: L. loa mf = 0.709; L. loa L3 = 0.716
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58.62% and 57.32%, respectively. Although the role of
albumin in the promotion of L. loa L3 moulting is
still to be elucidated, Ishima et al. [32] reported on
some beneficial effects from the interaction of
albumin with other biological factors such as insulin,
epidermal growth factor in the in vitro culture of
mammalian cells, suggesting that this combination of
BSA and LLC-MK2 as supplements provided optimal
in vitro conditions for L. loa L3 moulting. Smith et
al. [33] have developed a serum-free in vitro system
for Brugia malayi third infective larvae, by
supplementing RPMI 1640 with either arachidonic,
linoleic or linolenic acids and this supported consist-
ent and reproducible moulting to the fourth larval
stage in the presence of a basidiomycetous yeast,
Rhodotorula minuta. In serum-free cultures lacking R.
minuta, L3 larvae survive for upward of two weeks,
but did not moult. Smith & Rajan [34] subsequently
used this system to study the effect of tetracycline on
three different species of filarial nematodes, Brugia
malayi, Brugia pahangi and Dirofilaria immitis.
In summary, IMDM and DMEM were the two basic
media found to be more suitable to culture L. loa L3 and
mf, respectively, for short incubation time (for up to 7
days); DMEM + 5% NCS and IMDM + 10% FBS are suit-
able to culture both L. loa mf and L3 for relatively long in-
cubation time (for up to two weeks); DMEM + LLC-MK2
was suitable to culture L. loa mf for long incubation time
while DMEM + 1% BSA + LLC-MK2 provided optimal
moulting conditions for L. loa L3.
Conclusions
This study has demonstrated the effects of protein sup-
plemented basic media in association with or without
monkey kidney cells on the survivorship of L. loa micro-
filariae and on the survival and moulting of L. loa infect-
ive larvae. The findings from this work provide a range
of culture requirements for the maintenance of L. loa,
which are suitable for developing an effective platform
for drug screening.
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